These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 17720403)
1. Accessing the aortopulmonary window (#5) and the paraaortic (#6) lymph nodes in patients with non-small cell lung cancer. Cerfolio RJ; Bryant AS; Eloubeidi MA Ann Thorac Surg; 2007 Sep; 84(3):940-5. PubMed ID: 17720403 [TBL] [Abstract][Full Text] [Related]
2. Survival of patients with unsuspected N2 (stage IIIA) nonsmall-cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2008 Aug; 86(2):362-6; discussion 366-7. PubMed ID: 18640297 [TBL] [Abstract][Full Text] [Related]
3. Towards a minimally invasive staging strategy in NSCLC: analysis of PET positive mediastinal lesions by EUS-FNA. Annema JT; Hoekstra OS; Smit EF; Veseliç M; Versteegh MI; Rabe KF Lung Cancer; 2004 Apr; 44(1):53-60. PubMed ID: 15013583 [TBL] [Abstract][Full Text] [Related]
4. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors. Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650 [TBL] [Abstract][Full Text] [Related]
5. Survival of patients with true pathologic stage I non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2009 Sep; 88(3):917-22; discussion 922-3. PubMed ID: 19699920 [TBL] [Abstract][Full Text] [Related]
6. Predictors of survival and disease-free survival in patients with resected N1 non-small cell lung cancer. Cerfolio RJ; Bryant AS Ann Thorac Surg; 2007 Jul; 84(1):182-8; discussion 189-90. PubMed ID: 17588408 [TBL] [Abstract][Full Text] [Related]
7. Is palpation of the nonresected pulmonary lobe(s) required for patients with non-small cell lung cancer? A prospective study. Cerfolio RJ; Bryant AS J Thorac Cardiovasc Surg; 2008 Feb; 135(2):261-8. PubMed ID: 18242247 [TBL] [Abstract][Full Text] [Related]
8. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy? Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865 [TBL] [Abstract][Full Text] [Related]
9. Prolonged survival in patients with resected non-small cell lung cancer and single-level N2 disease. Keller SM; Vangel MG; Wagner H; Schiller JH; Herskovic A; Komaki R; Marks RS; Perry MC; Livingston RB; Johnson DH; J Thorac Cardiovasc Surg; 2004 Jul; 128(1):130-7. PubMed ID: 15224032 [TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound guided biopsy versus mediastinoscopy for analysis of paratracheal and subcarinal lymph nodes in lung cancer staging. Larsen SS; Vilmann P; Krasnik M; Dirksen A; Clementsen P; Skov BG; Jacobsen GK Lung Cancer; 2005 Apr; 48(1):85-92. PubMed ID: 15777974 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of main bronchial lymph nodes involvement in non-small cell lung carcinoma: N1 or N2? Rea F; Marulli G; Callegaro D; Zuin A; Gobbi T; Loy M; Sartori F Lung Cancer; 2004 Aug; 45(2):215-20. PubMed ID: 15246193 [TBL] [Abstract][Full Text] [Related]
12. The impact of multiple metastatic nodal stations on survival in patients with resectable N1 and N2 nonsmall-cell lung cancer. Kang CH; Ra YJ; Kim YT; Jheon SH; Sung SW; Kim JH Ann Thorac Surg; 2008 Oct; 86(4):1092-7. PubMed ID: 18805138 [TBL] [Abstract][Full Text] [Related]
13. Lung cancer staging: the value of ipsilateral scalene lymph node biopsy performed at mediastinoscopy. Lee JD; Ginsberg RJ Ann Thorac Surg; 1996 Aug; 62(2):338-41. PubMed ID: 8694587 [TBL] [Abstract][Full Text] [Related]
14. Sentinel node sampling limits lymphadenectomy in stage I non-small cell lung cancer. Muraoka M; Akamine S; Oka T; Tagawa T; Nakamura A; Tsuchiya T; Hayashi T; Nagayasu T Eur J Cardiothorac Surg; 2007 Aug; 32(2):356-61. PubMed ID: 17513118 [TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of routine mediastinoscopy in computed tomography- and positron emission tomography-screened patients with stage I lung cancer. Meyers BF; Haddad F; Siegel BA; Zoole JB; Battafarano RJ; Veeramachaneni N; Cooper JD; Patterson GA J Thorac Cardiovasc Surg; 2006 Apr; 131(4):822-9; discussion 822-9. PubMed ID: 16580440 [TBL] [Abstract][Full Text] [Related]
17. Complete thoracic mediastinal lymphadenectomy leads to a higher rate of pathologically proven N2 disease in patients with non-small cell lung cancer. Cerfolio RJ; Bryant AS; Minnich DJ Ann Thorac Surg; 2012 Sep; 94(3):902-6. PubMed ID: 22776083 [TBL] [Abstract][Full Text] [Related]
18. Endoscopic ultrasound-guided fine-needle aspiration when combined with positron emission tomography improves specificity and overall diagnostic accuracy in unexplained mediastinal lymphadenopathy and staging of non-small-cell lung cancer. Kalade AV; Eddie Lau WF; Conron M; Wright GM; Desmond PV; Hicks RJ; Chen R Intern Med J; 2008 Nov; 38(11):837-44. PubMed ID: 19120534 [TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer. Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121 [TBL] [Abstract][Full Text] [Related]
20. Restaging patients with N2 (stage IIIa) non-small cell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. Cerfolio RJ; Bryant AS; Ojha B J Thorac Cardiovasc Surg; 2006 Jun; 131(6):1229-35. PubMed ID: 16733150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]